In this study, we analyzed the relationship between ARHGAP25, RhoA, and VM in NSCLC and initially explored the effects of ARHGAP25 and RhoA on vascularization, hoping to determine their value in predicting NSCLC metastasis, prognosis, and targeted therapy. Here, RHOA is linked to non-small cell lung carcinoma.